Cannabis and Hemp Industry Investment News
2021 Half-time Report: As Adult-use Legalization Spreads Across the U.S., Federal Legislation, Social Equity Take Center Stage - Cannabis Business Exe...
by Simon Malinowski, Attorney at Harris Bricken Yesterday morning New York Governor Cuomo announced his resignation (which will take effect in 13 days...
By Tim K. Garrett & Ashley Li Tennessee recently enacted a minimal expansion of its medical marijuana law. The law took effect May 27, 2021, and it s...
By Oregon Small Business Association Florida state officials issued a consumer alert warning about hemp grown in Oregon containing rocks, sticks, and ...
Nevada’s marijuana industry is looking to get greener. From plastic packaging to the electricity needed to grow the plants, the cannabis industry has ...
Last year progressive voters were told that, despite the clear evidence that Joe Biden was a left-of-Reagan centrist, modern political pressures from ...
It challenges the conventional wisdom that the federal ban on marijuana gives legalization states free rein to discriminate against outsiders in their...
What should someone know before starting a cannabis business? To help aspiring entrepreneurs plan their own cannabis business, we asked business lead...
Key Points Planet 13 stock is over 30% below its peak from earlier this year. Business is booming for the cannabis company with even stronger growth l...
We believe Kathy Hochul may view cannabis as a popular initial (or near term) issue to champion at the start of her term thus gaining an initial win u...
A SECRETIVE United Nations body is in the process of drawing up its first ‘ill-informed’ Cannabis Initiative which may deliver a serious blow to the b...
First, cannabis dispensaries tried to channel the sophisticated look of an Apple Store. Now they’re embracing their inner Jimmy Buffett. It’s been a l...
THCVHS shows no signs of chromosomal or gene mutations in preclinical studies SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, has successfully completed genotoxicit...
SAN DIEGO, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("SKYE" or the "Company"), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has appointed Praveen Tyle, Ph.D., as an independent director to the Company's b...
SAN DIEGO, CA, June 10, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("SKYE" or the "Company"), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has expanded its Clinical Advisory Board with the appointment of ophthalmology e...
